A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

PHASE3CompletedINTERVENTIONAL
Enrollment

538

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1990

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (23)

10021

Cornell Univ Med Ctr, New York

10029

Mount Sinai Med Ctr, New York

14642

Univ of Rochester Medical Center, Rochester

15219

Hemophilia Ctr of Western PA / Univ of Pittsburgh, Pittsburgh

44106

Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland

55455

Univ of Minnesota, Minneapolis

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

70112

Tulane Univ School of Medicine, New Orleans

77030

Baylor College of Medicine, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

94305

Stanford Univ School of Medicine, Stanford

98105

Univ of Washington, Seattle

170330850

Milton S Hershey Med Ctr, Hershey

275997215

Univ of North Carolina, Chapel Hill

432101228

Ohio State Univ Hosp Clinic, Columbus

452670405

Holmes Hosp / Univ of Cincinnati Med Ctr, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

606143394

Chicago Children's Memorial Hosp, Chicago

921036325

Univ of California / San Diego Treatment Ctr, San Diego

021155724

Children's Hosp of Boston, Boston

01655

Univ of Massachusetts Med Ctr, Worcester

Unknown

Univ of Pittsburgh Med School, Pittsburgh

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001104 - A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia | Biotech Hunter | Biotech Hunter